Diagnosis and prevention of uric acid stones;Diagnostik und präevention des harnsäuresteins

Therapeutische Umschau

Volumn 61, Issue 9, 2004, Pages 571-574

  Ferrari, Paolo ^a   Bonny, O ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BICARBONATE; CALCIUM OXALATE; CALCIUM PHOSPHATE; CITRATE POTASSIUM; URIC ACID; URICOSURIC AGENT;

ALKALINIZATION; CHRONIC DIARRHEA; CRYSTALLIZATION; DEHYDRATION; GOUT; HUMAN; NEPHROLITHIASIS; REVIEW; RISK FACTOR; STONE FORMATION; TUBULAR DYSFUNCTION; URIC ACID STONE; URIC ACID URINE LEVEL; URINE PH; URINE VOLUME; UROLITHIASIS; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; FLUID THERAPY; HYPERURICEMIA; KIDNEY FUNCTION TEST; MALE; PH; URINE; URODYNAMICS;

ADULT; ALLOPURINOL; FEMALE; FLUID THERAPY; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERURICEMIA; KIDNEY CALCULI; KIDNEY FUNCTION TESTS; MALE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; URIC ACID; URICOSURIC AGENTS; URODYNAMICS;

EID: 4544286800     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.9.571     Document Type: Review

References (14)

1. Asplin JR. Uric acid stones. Semin Nephrol 1996; 16: 412-424.
2. Sorensen CM, Chandhoke PS. Hyperuricosuric calcium nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31: 915-925.
3. Shekarriz B, Stoller ML. Uric acid nephrolithiasis: current concepts and controversies. J Urol 2002; 168: 1307-1314.
4. Moe OW, Abate N, Sakhaee K. Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31: 895-914.
5. Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002; 62: 971-979.
6. Coe FL. Uric acid and calcium oxalate nephrolithiasis. Kidney Int 1983; 24: 392-403.
7. Low RK, Stoller ML. Uric acid-related nephrolithiasis. Urol Clin North Am 1997; 24: 135-148.
8. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 2001; 60: 757-761.
9. Pak CY, Poindexter JR, Adams-Huet B. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115: 26-32.
10. Riese RJ, Sakhaee K. Uric acid nephrolithiasis: pathogenesis and treatment. J Urol 1992; 148: 765-771.
11. Borghi L, Meschi T, Schianchi T, Allegri F, Guerra A, Maggiore U, Novarini A. Medical treatment of nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31: 1051-1064x.
12. Pak CY, Sakhaee K, Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 1986; 30: 422-428.
13. Wabner CL, Pak CY. Effect of orange juice consumption on urinary stone risk factors. J Urol 1993; 149: 1405-1408.
14. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315: 1386-1389.